JP2025522146A5 - - Google Patents

Info

Publication number
JP2025522146A5
JP2025522146A5 JP2025524504A JP2025524504A JP2025522146A5 JP 2025522146 A5 JP2025522146 A5 JP 2025522146A5 JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025522146 A5 JP2025522146 A5 JP 2025522146A5
Authority
JP
Japan
Application number
JP2025524504A
Other languages
Japanese (ja)
Other versions
JPWO2024010592A5 (https=
JP2025522146A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/036579 external-priority patent/WO2024010592A1/en
Publication of JP2025522146A publication Critical patent/JP2025522146A/ja
Publication of JPWO2024010592A5 publication Critical patent/JPWO2024010592A5/ja
Publication of JP2025522146A5 publication Critical patent/JP2025522146A5/ja
Pending legal-status Critical Current

Links

JP2025524504A 2022-07-08 2022-07-08 不眠症を治療するための医薬組成物および方法 Pending JP2025522146A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2022/036579 WO2024010592A1 (en) 2022-07-08 2022-07-08 Pharmaceutical compositions and methods for treating insomnia

Publications (3)

Publication Number Publication Date
JP2025522146A JP2025522146A (ja) 2025-07-10
JPWO2024010592A5 JPWO2024010592A5 (https=) 2025-07-17
JP2025522146A5 true JP2025522146A5 (https=) 2025-07-17

Family

ID=89453886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025524504A Pending JP2025522146A (ja) 2022-07-08 2022-07-08 不眠症を治療するための医薬組成物および方法

Country Status (7)

Country Link
US (1) US20250205218A1 (https=)
EP (1) EP4551220A1 (https=)
JP (1) JP2025522146A (https=)
CN (1) CN119255803A (https=)
AU (1) AU2022468585A1 (https=)
CA (1) CA3261198A1 (https=)
WO (1) WO2024010592A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12370198B2 (en) 2022-07-08 2025-07-29 La Pharmatech Inc Pharmaceutical compositions and methods for treating psychiatric disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10898493B2 (en) * 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
WO2021005189A1 (fr) * 2019-07-09 2021-01-14 Universite De Bretagne Occidentale (Ubo) Nouveaux composés inhibiteurs de la pfar

Similar Documents

Publication Publication Date Title
JP2025522146A5 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BY13143U (https=)
BY13145U (https=)
CN307050227S (https=)
CN307049712S (https=)
CN307049646S (https=)
CN307049608S (https=)
BY13151U (https=)
BY13150U (https=)
CN307049148S (https=)
CN307048822S (https=)
BY13149U (https=)
CN307048544S (https=)
CN307047752S (https=)
CN307045733S (https=)
CN307047282S (https=)
BY13140U (https=)
CN307047007S (https=)
CN307046414S (https=)
BY13144U (https=)
BY13164U (https=)